Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

Flow cytometry on a bone marrow aspirate from a 6-year-old boy with acute leukemia shows blasts positive for terminal deoxynucleotidyl transferase (TdT), cytoplasmic CD3, and CD7, with surface CD3 absent. This profile establishes lineage as:

  • A Natural killer cell neoplasm, since surface CD3 is absent
  • B B lymphoblastic, since TdT marks all lymphoid precursors
  • C T lymphoblastic, since cytoplasmic CD3 is the lineage-defining marker
  • D Indeterminate, requiring cytogenetics before classification
Correct answer: C. T lymphoblastic, since cytoplasmic CD3 is the lineage-defining marker

Explanation

Cytoplasmic CD3 expression is the most specific lineage-defining marker for T-cell origin and is present before surface CD3 appears during thymic maturation. TdT merely indicates immaturity and is shared by both B- and T-lymphoblastic leukemias, so option B fails. Absence of surface CD3 reflects an immature stage of T-cell differentiation rather than NK lineage. Cytogenetics refine risk stratification but do not determine lineage here.

Reference: Robbins and Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →